Mark your Calendars for Targeting Phage Therapy 2025
It is a great pleasure to announce the organization of the 8th World Conference on Targeting Phage Therapy on June 10-11, 2025 at DoubleTree by Hilton Berlin Kudamm, Berlin, Germany.
Keynote Speaker 2025: Professor Robert T. Schooley
It is a great pleasure to welcome Prof. Robert Schooley, from University of California, San Diego (USA) as a key note speaker during Targeting Phage Therapy 2025, this June in Berlin.He will present a talk on: Phage Therapy 2030: Getting from Here to There.
First Speakers Lineup 2025
Keynote Speech – Phage Therapy 2030: Getting from here to there
Robert T. SchooleyUniversity of California, San Diego, USA
Phage Therapy in Europe: Legal, Regulatory and Ethic Issues
Barbara BrennerKanzlei BRENNER, Germany
Biocontrol of Phage Resistance in Pseudomonas Infections – Fitness Trade-Offs Between Phages and Antibiotic Sensitivity
Jumpei FujikiRakuno Gakuen University, Japan
KlebPhaCol: Novel Gut Phage Order Associated with the Human Gut
Franklin NobregaUniversity of Southampton, United Kingdom
Yersinia Phage Stories: Impact on Phage Therapy
Mikael SkurnikUniversity of Helsinki, Finland
Phage Therapy in Veterinary Medicine: Presentation of First Clinical Trial in Japan
Hidetomo IwanoRakuno Gakuen University, Japan
Phage-Inspired Strategies for Tackling Mycobacterium abscessus Infections
Loris RizzelloUniversity of Milan, Italy
Key Dates 2025
Practical Session: How to Produce, Manufacture,
and Bring Phage Products to Market
This session provides a comprehensive and hands-on approach to the entire phage product lifecycle, from laboratory preparation to industrial-scale production and market entry. Experts will address both practical challenges and administrative requirements, ensuring that participants leave with actionable insights.
Key topics include: Technical & Manufacturing Aspects, Regulatory & Administrative Aspects, Business & Market Strategy.
Phage Therapy 2024: Towards Personalized Phage Therapy
The 7th World Conference on Targeting Phage Therapy 2024 on June 20-21 at Corinthia Palace in Malta was a great success. Over 40 presentations on the latest phage research were delivered to an audience of over 100 attendees representing 35 countries. Read more.
Speakers Lineup 2024
Keynote Speech: Clinical Trials in Phage Therapeutics: Looking Under the Hood
Robert T. SchooleyUniversity of California, San Diego, USA
Introduction to Targeting Phage Therapy 2024
Marvin EdeasINSERM – Institut Cochin, Université de Paris, France
Adaptive Phage Therapy in The Intensive Care Unit: From Science to Patients
Ekaterina ChernevskayaFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Russia
Magistral Phage Preparations: Is This the Model for Everyone?
Jean-Paul PirnayQueen Astrid Military Hospital, Belgium
Mycobacteriophages and Their Therapeutic Potential
Graham F. HatfullUniversity of Pittsburgh, USA
Regulatory restrictions vs. Human Rights, the Hippocratic oath and the Freedom of therapy– The legal aspect of phage therapy
Barbara BrennerKanzlei BRENNER, Germany
Phage Therapy: A Glimpse into Clinical Studies Involving Over 150 Cases
Nannan WuShanghai Public Health Clinical Center, Fudan University, China
Leveraging Evolutionary Trade-Offs in Development of Phage Therapy
Paul TurnerYale University, USA
Genetic Engineering of Phages to Target Intracellular Bloodstream E.coli Infections
Antonia P. SagonaUniversity of Warwick, United Kingdom
Quality control of phage Active Pharmaceutical Ingredients (APIs) in Belgium
Pieter-Jan CeyssensSciensano, Belgium
The Phageome in Normal and Inflamed Human Skin
Wolfgang WeningerMedical University of Vienna, Austria
Modern Concepts of Phage Therapy: An Immunologist’s Vision
Besarion LasareishviliEliava Institute of Bacteriophage, Microbiology and Virology, Georgia
Improving Phages Through Experimental Evolution
Frederic BertelsMax Planck Institute for Evolutionary Biology, Germany
Addressing Phage Resistance to Enhance the Robustness of Phage Therapy for Pseudomonas aeruginosa Infections in People with Cystic Fibrosis
Federica BrianiUniversity of Milan, Italy
Phage Satellites, a Diversity of Extradimensional Symbionts and Pathways to Phage Therapy
Rodrigo Ibarra ChávezUniversity of Copenhagen, Denmark
Towards efficient phage therapies: investigation of phage / bacteria equilibrium with metagenome of dark matter in natural samples
Domenico FrezzaUniversity of Roma Tor Vergata, Italy
Cell-Free Production of Personalized Therapeutic Phages Targeting Multidrug-Resistant Bacteria
Kilian VogeleInvitris, Germany
